XML 29 R16.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments

NOTE 5 – FINANCIAL INSTRUMENTS

Non-marketable Equity Securities

As of December 31, 2024 and 2023, other noncurrent assets included equity securities accounted for under the equity method with a carrying amount of $4.7 million and $4.9 million, respectively. No impairments to the carrying amount of the Company’s non-marketable equity securities were recognized in the years ended December 31, 2024, 2023, and 2022.

Derivatives Instruments

The Company uses a foreign exchange hedging strategy to hedge local currency expenses and reduce variability associated with anticipated cash flows. The Company’s derivative financial instruments consist of foreign currency forward contracts. The maturities of these instruments are generally less than twelve months. Fair values for derivative financial instruments are based on prices computed using third-party valuation models. All the significant inputs to the third-party valuation models are observable in active markets. Inputs include current market-based parameters such as forward rates, yield curves, and credit default swap pricing.

Cash Flow Hedges

The Company designates certain foreign currency forward contracts as hedging instruments pursuant to ASC 815, Derivatives and Hedging. The effective portion of the gain or loss on the derivatives are reported as a component of accumulated other comprehensive loss (“AOCL”) in stockholders’ equity and reclassified into earnings in the consolidated statements of operations in the period upon which the hedged transactions are settled.

The notional and fair values of all derivative instruments were as follows (in thousands):

 

 

 

 

December 31,

 

 

 

Location in Balance Sheet

 

2024

 

 

2023

 

Derivative instruments designated as cash flow hedges:

 

 

 

 

 

 

 

 

Fair value—foreign exchange contract assets, net amount

 

Prepaid expenses and other current assets

 

$

 

 

$

1,184

 

Fair value—foreign exchange contract liabilities, net amount

 

Accrued liabilities

 

$

1,858

 

 

$

 

 

 

 

 

 

 

 

 

 

Notional value held to buy U.S. dollars in exchange for other currencies

 

 

 

$

5,074

 

 

$

738

 

Notional value held to sell U.S. dollars in exchange for other currencies

 

 

 

$

57,329

 

 

$

45,468

 

All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparty to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company’s consolidated balance sheets on a net basis.

The gross amounts of the Company’s foreign currency forward contracts and the net amounts recorded in the Company’s consolidated balance sheets were as follows (in thousands):

 

 

December 31,

 

 

 

2024

 

 

2023

 

Gross amount of recognized assets

 

$

173

 

 

$

1,300

 

Gross amount of recognized liabilities

 

 

(2,031

)

 

 

(116

)

Net (liabilities) assets

 

$

(1,858

)

 

$

1,184

 

The changes in AOCL related to the cash flow hedges consisted of the following (in thousands):

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Beginning balance

 

$

1,034

 

 

$

(94

)

 

$

 

Other comprehensive (loss) gain before reclassification

 

 

(2,107

)

 

 

1,190

 

 

 

(94

)

Amounts reclassified from accumulated other comprehensive loss into net loss

 

 

(785

)

 

 

(62

)

 

 

 

Net current period other comprehensive (loss) gain

 

 

(2,892

)

 

 

1,128

 

 

 

(94

)

Ending balance

 

$

(1,858

)

 

$

1,034

 

 

$

(94

)

The following table summarizes the gains recognized upon settlement of the hedged transactions in the consolidated statement of operations for the years ended December 31, 2024 and 2023 (in thousands):

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

690

 

 

$

841

 

Selling, general and administrative

 

 

74

 

 

 

192

 

Total

 

$

764

 

 

$

1,033

 

There were no gains or losses recognized in the year ended December 31, 2022 as there was no settlement of any hedged transactions.

Undesignated Derivatives

For derivatives that were not designated as hedge instruments, they were measured and reported at fair value as a derivative asset or liability in the consolidated balance sheets with their corresponding changes in the fair value recognized as gains or

losses in interest and other income, net in the consolidated statements of operations. These instruments were all re-designated as foreign currency cash flow hedges in July 2023.